Skip to content

Clinical trials

Phase 3 Fibrosis trials in France

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Fibrosis Phase: Phase 3 Country / region: France Clear all

29 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20031
20042
20071
20081
20093
20101
20121
20131
20144
20153
20161
20171
20183
20211
20221
20231
20242

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed18
Terminated4
Recruiting2
Active, not recruiting2
Suspended1
Unknown status1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Assistance Publique - Hôpitaux de Paris8
Gilead Sciences3
89bio, Inc.2
AbbVie2
Centre Hospitalier Universitaire de Besancon2
Centre Hospitalier Universitaire, Amiens2
Vertex Pharmaceuticals Incorporated2
Bristol-Myers Squibb1
Genfit1
Institut de Cancérologie de Lorraine1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Fibrosis29
Hepatitis C5
Non-alcoholic Fatty Liver Disease4
Digestive System Diseases3
Hepatitis C, Chronic3
Liver Diseases3
Ascites2
Carcinoma, Hepatocellular2
Cystic Fibrosis2
Fatty Liver2

Trials

Showing 1 to 25 of 29. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.